AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

CHI’s 9th Annual Clinical Trial Innovation Summit

April 6-8, 2020  |  Cambridge, MA

From the producers of SCOPE: Summit for Clinical Ops Executives, is CHI’s 9th Annual Clinical Trial Innovation Summit to be held on April 6-8, 2020, in Cambridge, MA. Hear from clinical ops leaders & clinical research innovators from pharma, biotech and academia for the perfect blend of high-quality presentations and intimate networking. Through case studies, workshops, panel & roundtable breakout discussions and an active exhibit hall, the summit delivers the real-world experiences and best practices needed to optimize clinical trial innovation, planning and management.

 

Join Avoca for the following sessions:

 

Wednesday, April 8 at 8:35am

PANEL DISCUSSION: Effective Contracting as a Vehicle to Increase Quality and Mitigate Risk

Clinical trials rely on vendors and partners to carry out numerous tasks – something that comes with an inherent risk. This panel will discuss the latest trends in vendor oversight and contracting and how to mitigate risk and build in quality-by-design with vendors and partners using effective contracting strategies. Panelists will discuss the pros and cons of common oversight and risk mitigation approaches supported by effective contracting, including quality agreements, metrics, and incentive/penalty clauses, as well as the impact these have on the contracts process and downstream clinical operations.

Moderator: Mai Nguyen, MPH, Senior Consultant, The Avoca Group

Panelists:

  • Bella Sessoms, MPH, Director, Portfolio Sourcing Management, Portfolio Sourcing and Relationship Management, Astellas Pharma Global Development
  • Chuck Bradley, Vice President, Clinical Development, FibroGen, Inc.
  • Jay Zinni, Director, R&D Procurement, Incyte
  • Andy Lawton, Director & Consultant, Risk Based Approach Ltd.

 

Wednesday, April 8 at 11:45am

TABLE: FSP vs. Hybrid vs. Strategic Partnership Outsourcing – Choosing an Appropriate Model

INTERACTIVE ROUNDTABLE BREAKOUT DISCUSSION

  • Strategies for choosing an appropriate outsourcing model for individual trials vs. the entire portfolio
  • Determining pros and cons of each model – cost, resources, performance, study start-up
  • Determining sourcing needs vs. budget vs. relationships with previous and new partners

Moderators:

  • Mai Nguyen, MPH, Senior Consultant, The Avoca Group
  • Cameron McClure, PMP, PMI-ACP, CSM, CCRP, Senior Manager, Clinical Business Operations, BeiGene
  • Bella Sessoms, MPH, Director, Portfolio Sourcing Management, Portfolio Sourcing and Relationship Management, Astellas Pharma Global Development
  • Chuck Bradley, Vice President, Clinical Development, FibroGen, Inc.
  • Debora Araujo, Founder & CEO, ClinBiz
  • Karen McCarthy Schau, Director, Global Clinical Operations, Vertex Pharmaceuticals
  • Moderator to be Announced, YourEncore